Newly approved brain cancer drug has ties to Duke University
The newly FDA-approved brain cancer therapy Voranigo (vorasidenib) has its roots in North Carolina. It is the product of research by Duke University's Darell Bigner and Bert Vogelstein of Johns Hopkins University and underwent clinical trials at Duke. …